Occupe actuellement un poste chez Apellis Pharmaceuticals Inc
Position | Company | Period |
---|---|---|
General Counsel, Vice President of Corporate Development | Apellis Pharmaceuticals Inc | 1 janvier 2014 - |
Rechercher
Date de notification | Date de transaction | A/V Type de transaction |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur totale | Détails | |
---|---|---|---|---|---|---|---|---|
2024-02-13 | 2024-02-12 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
781
-0.7%
67,7752 926 USD |
781 -0.7% | 67,77 | 52 926 USD | |
2024-01-31 | 2024-01-29 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
906
-0.9%
64,1458 109 USD |
906 -0.9% | 64,14 | 58 109 USD | |
2024-01-23 | 2024-01-22 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
4 184
-3.8%
65,00271 943 USD |
4 184 -3.8% | 65,00 | 271 943 USD | |
2024-01-17 | 2024-01-16 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
4 240
-3.7%
66,81283 268 USD |
4 240 -3.7% | 66,81 | 283 268 USD | |
2023-12-20 | 2023-12-19 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
2 300
-2.5%
57,38131 980 USD |
2 300 -2.5% | 57,38 | 131 980 USD | |
2023-12-20 | 2023-12-19 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
1 605
-1.7%
57,0091 492 USD |
1 605 -1.7% | 57,00 | 91 492 USD | |
2023-07-06 | 2023-07-03 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
8 510
-9.0%
89,98765 730 USD |
8 510 -9.0% | 89,98 | 765 730 USD | |
2022-06-23 | 2022-06-22 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
10 000
-8.0%
44,51445 140 USD |
10 000 -8.0% | 44,51 | 445 140 USD | |
2022-04-27 | 2022-04-25 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
5 000
-3.8%
50,00250 000 USD |
5 000 -3.8% | 50,00 | 250 000 USD | |
2021-12-23 | 2021-12-22 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
300
-0.3%
48,5814 573 USD |
300 -0.3% | 48,58 | 14 573 USD | |
2021-12-23 | 2021-12-22 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
5 097
-4.5%
47,86243 917 USD |
5 097 -4.5% | 47,86 | 243 917 USD | |
2021-12-23 | 2021-12-22 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
5 174
-4.7%
47,72246 883 USD |
5 174 -4.7% | 47,72 | 246 883 USD | |
2020-12-15 | 2020-12-14 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
200
-0.5%
55,9111 182 USD |
200 -0.5% | 55,91 | 11 182 USD | |
2020-12-15 | 2020-12-14 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
900
-2.0%
55,0049 501 USD |
900 -2.0% | 55,00 | 49 501 USD | |
2020-12-15 | 2020-12-14 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
900
-2.0%
53,8648 475 USD |
900 -2.0% | 53,86 | 48 475 USD | |
2020-12-15 | 2020-12-14 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
1 163
-2.5%
52,7361 322 USD |
1 163 -2.5% | 52,73 | 61 322 USD | |
2020-12-15 | 2020-12-14 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
2 526
-5.1%
51,32129 624 USD |
2 526 -5.1% | 51,32 | 129 624 USD | |
2020-12-15 | 2020-12-14 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
2 709
-5.2%
50,61137 094 USD |
2 709 -5.2% | 50,61 | 137 094 USD | |
2020-12-15 | 2020-12-11 |
Apellis Pharmaceuticals Inc
(APLS)
|
V Vente |
9 935
-18.6%
50,00496 750 USD |
9 935 -18.6% | 50,00 | 496 750 USD | |
2020-02-12 | 2020-02-10 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
5 000
-12.4%
44,50222 500 USD |
5 000 -12.4% | 44,50 | 222 500 USD | |
2020-01-28 | 2020-01-27 |
Apellis Pharmaceuticals Inc
(APLS)
|
VP Vente planifiée |
3 000
-13.6%
40,47121 401 USD |
3 000 -13.6% | 40,47 | 121 401 USD |